These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26779375)

  • 21. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
    Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition.
    Santibanez JF; Obradović H; Kukolj T; Krstić J
    Dev Dyn; 2018 Mar; 247(3):382-395. PubMed ID: 28722327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
    Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
    Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
    Kim S; Lee J; Jeon M; Nam SJ; Lee JE
    Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
    Teixeira AF; Ten Dijke P; Zhu HJ
    Front Cell Dev Biol; 2020; 8():605. PubMed ID: 32733895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metastasis suppressor CD82/KAI1 represses the TGF-β
    Lee MS; Lee J; Kim YM; Lee H
    Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
    Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
    Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
    Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
    Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
    Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
    Baruah MM; Khandwekar AP; Sharma N
    Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
    Sun XD; Liu XE; Huang DS
    Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and ex vivo vanadium antitumor activity in (TGF-β)-induced EMT. Synergistic activity with carboplatin and correlation with tumor metastasis in cancer patients.
    Petanidis S; Kioseoglou E; Domvri K; Zarogoulidis P; Carthy JM; Anestakis D; Moustakas A; Salifoglou A
    Int J Biochem Cell Biol; 2016 May; 74():121-34. PubMed ID: 26916505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression.
    Jones E; Pu H; Kyprianou N
    Expert Opin Ther Targets; 2009 Feb; 13(2):227-34. PubMed ID: 19236240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical and biological roles of transforming growth factor beta in colon cancer stem cells: A systematic review.
    Chruścik A; Gopalan V; Lam AK
    Eur J Cell Biol; 2018 Jan; 97(1):15-22. PubMed ID: 29128131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.
    Sommerova L; Ondrouskova E; Vojtesek B; Hrstka R
    BMC Cancer; 2017 Aug; 17(1):546. PubMed ID: 28810836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
    Juang YL; Jeng YM; Chen CL; Lien HC
    Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.